| |
Pharmacokinetic Enhancement of HCV Protease
Inhibitors with Ritonavir: More Than It Seems?
|
| |
| |
Reported by Jules Levin
Dale Kempf, Barry Bernstein, Daniel Bow, David Beno, William Chiou, JŸrgen Delzer, Jinrong Liu, Kennan Marsh, Keith McDaniel, Rajeev Menon, Tim Middleton, Jianwei Shen, Richard Voorman
5th International Workshop on Clinical Pharmacology of Hepatitis Therapy, June 23, 2010
Acknowledgments: Nancy Shulman (Roche), Rob Ralston (Merck/Schering), Enanta Pharmaceuticals
|
|
| |
| |
|
|
|
